Markets

Insider Trading

Hedge Funds

Retirement

Opinion

Dividend Capture Strategy: 5 High-Yield Stocks to Buy in February

In this article, we discuss 5 high-yield stocks to buy in February. If you want to read our detailed analysis on dividend capture strategy and past performance of high dividend stocks, go directly to read Dividend Capture Strategy: 10 High-Yield Stocks to Buy in February

5. Shell plc (NYSE:SHEL)

Ex-Dividend Date: February 16
Dividend Yield as of February 6: 3.89%

Shell plc (NYSE:SHEL) is a London-based multinational oil and gas company that also specializes in petrochemicals. On February 2, the company declared a 15% hike in its quarterly dividend to $0.575/ADS per share. The stock will be trading ex-dividend on February 16. As of February 6, the stock has a dividend yield of 3.89%, coming through as one of the high-yield stocks on our list.

In December, Piper Sandler maintained an Overweight rating on Shell plc (NYSE:SHEL) with a $70 price target, appreciating the company’s outperformance in the last two years.

In Q4 2022, Shell plc (NYSE:SHEL) reported revenue of $101.3 billion, up 18.8% from the same period last year. The company’s operating cash flow for the quarter came in at $22.4 billion and its free cash flow stood at $15.4 billion. It returned $6.3 billion to shareholders in dividends during the quarter.

As of the close of Q3 2022, 39 hedge funds in Insider Monkey’s database owned stakes in Shell plc (NYSE:SHEL), the same as in the previous quarter. The collective value of these stakes is over $3.1 billion. Fisher Asset Management owned the largest stake in the company, worth over $1 billion.

Harding Loevner mentioned Shell plc (NYSE:SHEL) in its Q1 2022 investor letter. Here is what the firm has to say:

“While risks of unforeseen consequences arising from the Ukraine conflict are high, on this front we are cautiously optimistic that China will work hard to maintain its neutrality in a credible way, as it is a huge beneficiary of trade with the rest of the world, especially the rich developed nations. We think it likely that China, along with India, will continue to buy oil and gas from Russia (just as Europe, at least for now, plans to keep its gas pipelines open), and do not expect that fact to alter China’s trade relations with the West much. Nevertheless, we must contemplate that our optimism is misplaced on the importance of membership in the global network of exchange. If our central and optimistic case—admittedly an educated guess—is wrong, then we’d need to greatly modify our views of which companies in our opportunity set will face new barriers to profitable growth, and which might stand to benefit, relatively, from a further receding of globalization. (Global trade, after all, has never matched the peak share of GDP it reached in 2008, before the Global Financial Crisis.) We’d expect such a world to be less efficient, as the cold logic of comparative advantage is demoted as a determinant of which goods or services are produced and where. That would lead to a less prosperous world, since exploiting comparative advantage is a cornerstone of wealth creation. If regional blocs began to raise limits on the movement of capital as well as goods, we’d need to parse which of our multi-national companies were at risk of declining sales from increasingly hostile, siloed countries. Royal Dutch Shell (NYSE:SHEL) has found its Siberian oil and gas joint venture assets stranded by the combination of sanctions and the public opprobrium of Russia’s actions.”

Follow Shell Plc (NYSE:SHEL)

4. Brookfield Renewable Partners L.P. (NYSE:BEP)

Ex-Dividend Date: February 27
Dividend Yield as of February 6: 4.72%

Brookfield Renewable Partners L.P. (NYSE:BEP) is a Bermuda-based renewable energy company that owns related power assets. In January, JonesResearch initiated its coverage of the stock with a Buy rating and a $37 price target. The firm mentioned that the company has ‘abundant growth ahead’.

On February 3, Brookfield Renewable Partners L.P. (NYSE:BEP) declared a quarterly dividend of $0.3375 per share, having raised it by 5.5%. This was the company’s 12th consecutive year of dividend growth. This high-yield dividend stock’s yield came in at 4.72% on February 6. The stock will be trading ex-dividend on February 27.

At the end of Q3 2022, 19 hedge funds in Insider Monkey’s database owned stakes in Brookfield Renewable Partners L.P. (NYSE:BEP), worth $161.2 million. With nearly 2 million shares, Select Equity Group was the company’s leading stakeholder in Q3.

Follow Brookfield Renewable Partners L.p. (NYSE:BEP)

3. Gilead Sciences, Inc. (NASDAQ:GILD)

Ex-Dividend Date: March 14
Dividend Yield as of February 6: 3.47%

Gilead Sciences, Inc. (NASDAQ:GILD) is an American biopharmaceutical company, based in California. The company specializes in the research and development of antiviral drugs. In February, Piper Sandler raised its price target on the stock to $112 with an Overweight rating on the shares, noting the company’s commercial business.

Gilead Sciences, Inc. (NASDAQ:GILD) started paying dividends in 2015 and has raised its payouts every year since then. It currently pays a quarterly dividend of $0.75 per share, raising it by 2.7% on February 2. The stock’s dividend yield on February 6 came in at 3.47% and it will go ex-dividend on March 14.

At the end of Q3 2022, 56 hedge funds tracked by Insider Monkey owned stakes in Gilead Sciences, Inc. (NASDAQ:GILD), valued at $3.63 billion collectively.

Ariel Investments mentioned Gilead Sciences, Inc. (NASDAQ:GILD) in its Q3 2022 investor letter. Here is what the firm has to say:

“At the stock level, biopharmaceutical company Gilead Sciences, Inc. (NASDAQ:GILD) was the top contributor in the quarter based on positive data released in a study evaluating Trodelvy versus comparative chemotherapy in patients with metastatic breast cancer. The detailed findings increased investor confidence the drug would receive incremental approvals for a broader range of breast cancer treatments. Shares also received a boost on news the TAF patent portfolio for HIV drugs will be extended from the middle of this decade through the early 2030s, thereby lengthening the company’s long-term opportunity in the virology market.”

Follow Gilead Sciences Inc. (NASDAQ:GILD)

2. UGI Corporation (NYSE:UGI)

Ex-Dividend Date: March 14
Dividend Yield as of February 6: 3.55%

UGI Corporation (NYSE:UGI) is an American natural gas and electric power distribution company. The company has been raising its dividends consistently for the past 35 years and maintains a dividend-paying streak of 138 years. It currently offers a quarterly dividend of $0.36 per share with a dividend yield of 3.55%, as of February 6. The stock will go ex-dividend on March 14.

In fiscal Q1 2023, UGI Corporation (NYSE:UGI) reported revenue of $2.76 billion, which saw a 3.4% growth from the same period last year. The company had available liquidity of approximately $1.2 billion.

At the end of Q3 2022, 26 hedge funds tracked by Insider Monkey reported owning stakes in UGI Corporation (NYSE:UGI), up from 24 in the previous quarter. These stakes are worth over $152 million collectively.

Diamond Hill Capital mentioned UGI Corporation (NYSE:UGI) in its Q3 2022 investor letter. Here is what the firm has to say:

“UGI Corporation (NYSE:UGI), a natural gas and electric power utility, generates approximately one-third of its revenue through its European propane distribution business. The European energy market dislocation and subsequent inflation have raised fears of significant volume and price contraction, pressuring UGI’s share price. Longer term, we believe UGI’s investments into renewable/alternative energy sources position it well. In the nearer term, it should continue to have an advantage delivering fuel to rural locations that are not easily served by gas pipelines — whether that fuel is propane, liquified petroleum gas (LPG), renewable natural gas (RNG) or other alternative fuels.”

Follow Ugi Corp (NYSE:UGI)

1. BCE Inc. (NYSE:BCE)

Ex-Dividend Date: March 14
Dividend Yield as of February 6: 6.31%

A Canadian communications company, BCE Inc. (NYSE:BCE) tops our list of high-yield dividend stocks to buy. The company pays a quarterly dividend of C$0.9675 per share and has a dividend yield of 6.31%, as of February 6. It has been rewarding shareholders with increased dividends for over five years. The stock will be trading ex-dividend on March 14.

As of the close of Q3 2022, 10 hedge funds owned stakes in BCE Inc. (NYSE:BCE), as per Insider Monkey’s database. The collective value of these stakes is over $82 million. Among these hedge funds, Renaissance Technologies was the company’s leading stakeholder in Q3.

Follow Bce Inc (NYSE:BCE)

You can also take a look at 10 Best February Dividend Stocks To Buy and 13 Cheap DRIP Stocks To Buy Now

Follow Insider Monkey on Twitter

The $250 Trillion AI Hype is Real. A few years from now, you’ll probably wish you’d bought this stock.

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

When Jeff Bezos said that one breakthrough technology would shape Amazon’s destiny, even Wall Street’s biggest analysts were caught off guard.

Fast forward a year and Amazon’s new CEO Andy Jassy described generative AI as a “once-in-a-lifetime” technology that is already being used across Amazon to reinvent customer experiences.

At the 8th Future Investment Initiative conference, Elon Musk predicted that by 2040 there would be at least 10 billion humanoid robots, with each priced between $20,000 and $25,000.

Do the math. According to Musk, this technology could be worth $250 trillion by 2040.

Put another way, that’s roughly equal to:

  • 175 Teslas
  • 107 Amazons
  • 140 Metas
  • 84 Googles
  • 65 Microsofts
  • And 55 Nvidias

And here’s the wild part — this $250 trillion wave isn’t tied to one company, but to an entire ecosystem of AI innovators set to reshape the global economy.

It’s a leap so massive, it could reshape how businesses, governments, and consumers operate worldwide.

Even if that $250 trillion figure sounds ambitious, major firms like PwC and McKinsey still see AI unlocking multi-trillion-dollar potential.

How could anything be worth that much?

The answer lies in a breakthrough so powerful it’s redefining how humanity works, learns, and creates.

And this breakthrough has already set off a frenzy among hedge funds and Wall Street’s top investors.

What most investors don’t realize is that one under-owned company holds the key to this $250 trillion revolution.

In fact, Verge argues this company’s supercheap AI technology should concern rivals.

Before I reveal the details, let’s talk about how some of the richest people on the planet are positioning themselves.

  • Bill Gates sees artificial intelligence as the “biggest technological advance in my lifetime,” more transformative than the internet or personal computer, capable of improving healthcare, education, and addressing climate change.
  • Larry Ellison — through Oracle, is spending billions on Nvidia chips and partnering with Cohere to embed generative AI across Oracle’s cloud and apps.
  • Warren Buffett — not known for tech hype — says this breakthrough could have a ‘hugely beneficial social impact.

When billionaires from Silicon Valley to Wall Street line up behind the same idea — you know it’s worth paying attention to.

Even as we admire what Tesla, Nvidia, Alphabet, and Microsoft have built, we believe an even greater opportunity lies elsewhere…

But the real story isn’t Nvidia — it’s a much smaller company quietly improving the critical technology that makes this entire revolution possible.

And judging by what I’m hearing from both Silicon Valley insiders and Wall Street veterans…

This prediction might not be bold at all:

A few years from now, you’ll wish you’d owned this stock.

The best part? You can discover everything about this company and its groundbreaking technology right now.

I’ve compiled everything you need to know about this groundbreaking company in a detailed, members-only report.

Trust me — you’ll want to read this report before putting another dollar into any tech stock.

For a ridiculously low price of just $9.99 a month, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single fast food meal!

Here’s what to do next:

1. Subscribe to our Premium Readership Newsletter for just $9.99 a month. (33% Off – was $14.99).

2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

<b>Cancel anytime.</b> Turn off auto-renewal via our website with just a click.

 

Buy This $3 Stock Now Before the 400% Surge Begins

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

My name is Inan Dogan. I’m the co-founder and Research Director of Insider Monkey. I have an important message for you today.

Since March 2017, my stock picks have returned 16.5% annually. Today, I’ve found an opportunity even bigger than my British American Tobacco call.

Two years ago, Wall Street wrote off British American Tobacco (BTI) as a “melting ice cube.” The stock had crashed 40% from its peak, and consensus said the business was dying.

We looked under the cover and realized they were wrong.

We alerted our subscribers, and BTI returned 90% in just 16 months.

Now if you had invested just $10,000 in BTI in June 2024, you’d be sitting on $19,000 in October 2025.

Today, we have identified a nearly identical pattern in a digital-first giant trading at $3.

While the market panics over a surface-level revenue decline, our PhD-led research shows management has actually surgically cut $100 million in waste to focus on high-margin growth.

This pattern is a hallmark of our 16.5% annual return track record. The current opportunity offers a 400% upside potential—dwarfing even our 90% BTI return.

Get the ticker for our new “Underdog” pick and the full BTI case study for just 99 cents.

This exclusive offer is for NEW newsletter subscribers ONLY! Join our Premium Readership Newsletter for only $0.99 and become part of a savvy investor community.!

This offer vanishes in 7 days, so don’t miss your chance to lock in market beating returnsSign up NOW! The monthly newsletter comes with a 30-day, no-risk money-back guarantee. This offer is available to the first 1000 new investors who respond.

Regular price $9.99/mo. Cancel anytime.

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $0.99.

2. Enjoy a month of ad-free browsing, exclusive access to our in-depth report on the Trump tariff and nuclear energy company as well as the revolutionary AI-robotics company, and the upcoming issues of our Premium Readership Newsletter.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

Regular price $9.99/mo. Cancel anytime.